ADO 8.70% 2.1¢ anteotech ltd

Saliva Clinical Trial, page-4

  1. 5,197 Posts.
    lightbulb Created with Sketch. 1439
    I’m with @Stockcount and have been saying for months - time is not our friend.
    We’re jumping into the tender process where the quality of our tests might make way for someone cheaper or with established networks. It’s a slow climb.
    We need our Ellume moment.
    Last edited by ArtVandelay: 29/05/21
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.